LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: The Accuracy of a Home-performed Faecal Calprotectin Test in Paediatric Patients With Inflammatory Bowel Disease.

    Lerchova, Tereza / Hradsky, Ondrej / Copova, Ivana / Potuznikova, Kristyna / Gonsorcikova, Lucie / Bronsky, Jiri

    Journal of pediatric gastroenterology and nutrition

    2019  Volume 69, Issue 1, Page(s) 75–81

    Abstract: Objectives: Owing to the invasiveness of endoscopy, the use of biomarkers, especially faecal calprotectin (FC), has become standard for remission assessment. This study aimed to compare the accuracy for detection of endoscopic activity using recently ... ...

    Abstract Objectives: Owing to the invasiveness of endoscopy, the use of biomarkers, especially faecal calprotectin (FC), has become standard for remission assessment. This study aimed to compare the accuracy for detection of endoscopic activity using recently developed FC home test using smartphone application (FC-IBDoc) against standard enzyme-linked immunosorbent assay (ELISA).
    Methods: In all, 102 consecutive observations (89 participants) were included in prospective observational study. FC-IBDoc was performed parallelly with FC-ELISA in paediatric patients with inflammatory bowel disease indicated for endoscopy. Both tests were performed by trained staff. Mucosal healing was defined using Simple Endoscopic Score for Crohn disease (CD) ≤2 in patients with CD (n = 44), ulcerative colitis (UC) Endoscopic Index of Severity ≤4 in patients with UC (n = 27) and Rutgeerts score i0 and i1 without colon involvement in patients with CD after ileocaecal resection (n = 19).
    Results: Out of 102 endoscopic findings 23 were assessed as mucosal healing. We found an association of the mucosal healing scores of the entire group both with FC-ELISA (P = 0.002) and FC-IBDoc (P = 0.001). The area under the receiver operating characteristic curve for FC-ELISA was 0.883 (95% confidence interval 0.807-0.960), with optimal cut-off at 136.5 μg/g. The area under the receiver operating characteristic curve for FC-IBDoc was 0.792 (95% confidence interval 0.688-0.895) with optimal cut-off at 48 μg/g. The FC-ELISA was more accurate than FC-IBDoc when tested by a Delong test (P = 0.023).
    Conclusions: Standard FC-ELISA for FC evaluation is more reliable predictor of mucosal healing than the FC-IBDoc in paediatric patients with inflammatory bowel disease. The cut-off values for both tests were incongruous.
    MeSH term(s) Adolescent ; Area Under Curve ; Biomarkers/analysis ; Child ; Colitis, Ulcerative/diagnostic imaging ; Colitis, Ulcerative/metabolism ; Crohn Disease/diagnostic imaging ; Crohn Disease/metabolism ; Endoscopy, Gastrointestinal ; Enzyme-Linked Immunosorbent Assay ; Feces/chemistry ; Female ; Humans ; Intestinal Mucosa/diagnostic imaging ; Intestinal Mucosa/physiopathology ; Leukocyte L1 Antigen Complex/analysis ; Male ; Mobile Applications ; Prospective Studies ; ROC Curve ; Reagent Kits, Diagnostic/standards ; Reproducibility of Results ; Self Care ; Severity of Illness Index ; Smartphone ; Wound Healing
    Chemical Substances Biomarkers ; Leukocyte L1 Antigen Complex ; Reagent Kits, Diagnostic
    Language English
    Publishing date 2019-03-21
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Observational Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 603201-1
    ISSN 1536-4801 ; 0277-2116
    ISSN (online) 1536-4801
    ISSN 0277-2116
    DOI 10.1097/MPG.0000000000002331
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Correction to: Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease.

    Copova, Ivana / Hradsky, Ondrej / Zarubova, Kristyna / Gonsorcikova, Lucie / Potuznikova, Kristyna / Lerchova, Tereza / Nevoral, Jiri / Bronsky, Jiri

    European journal of pediatrics

    2018  Volume 177, Issue 11, Page(s) 1695

    Abstract: This article was originally published with all author names incorrectly listed. All author names have now been transposed and appear correctly above. The original article was corrected. ...

    Abstract This article was originally published with all author names incorrectly listed. All author names have now been transposed and appear correctly above. The original article was corrected.
    Language English
    Publishing date 2018-10-02
    Publishing country Germany
    Document type Journal Article ; Published Erratum
    ZDB-ID 194196-3
    ISSN 1432-1076 ; 0340-6199 ; 0943-9676
    ISSN (online) 1432-1076
    ISSN 0340-6199 ; 0943-9676
    DOI 10.1007/s00431-018-3260-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease.

    Copova, Ivana / Hradsky, Ondrej / Zarubova, Kristyna / Gonsorcikova, Lucie / Potuznikova, Kristyna / Lerchova, Tereza / Nevoral, Jiri / Bronsky, Jiri

    European journal of pediatrics

    2018  Volume 177, Issue 11, Page(s) 1685–1693

    Abstract: Exclusive enteral nutrition (EEN) has been recommended as the first-line therapy in children with active Crohn disease (CD). The primary aim of our study was to determine whether it is possible to use the difference between basal fecal calprotectin (F- ... ...

    Abstract Exclusive enteral nutrition (EEN) has been recommended as the first-line therapy in children with active Crohn disease (CD). The primary aim of our study was to determine whether it is possible to use the difference between basal fecal calprotectin (F-CPT) and the value at week 2 of EEN to predict clinical response at week 6. We prospectively collected stool samples for F-CPT analysis and clinical and laboratory parameters during EEN from 38 pediatric patients (28 boys, median age 12.8 years) with newly diagnosed active luminal CD. The difference between F-CPT concentrations before EEN and at week 2 did not predict clinical non-response at week 6 (OR 0.9996 95% CI 0.9989-1.0002, p = 0.18); however, it predicted patients who did not achieve clinical remission at week 6 (OR 0.9993, 95% CI 00.9985-0.9998, p = 0.006) with sensitivity of 58%, and specificity of 92% for cut-off of F-CPT increase by 486 μg/g.Conclusions: An early decrease in F-CPT levels in children with newly diagnosed active luminal CD did not predict clinical response at week 6 of EEN induction therapy, and clinical remission was predicted with low accuracy. Therefore, F-CPT cannot be used as a predictor to select the patients in whom EEN should be terminated. What is Known: • The fecal calprotectin (F-CPT) is an important marker of intestinal inflammation. • Approximately 25% of pediatric patients with Crohn disease (CD) do not achieve clinical remission, and there is still no sufficient predictor of response to exclusive enteral nutrition (EEN) treatment. What is New: • The difference between the F-CPT concentrations before EEN treatment and at week 2 did not predict clinical response to treatment at week 6, even if it predicted clinical remission, however, with low accuracy. F-CPT is not a suitable predictor to select the patients for discontinuing of EEN induction therapy.
    MeSH term(s) Adolescent ; Biomarkers/analysis ; Child ; Crohn Disease/metabolism ; Crohn Disease/therapy ; Enteral Nutrition/adverse effects ; Feces/chemistry ; Female ; Humans ; Leukocyte L1 Antigen Complex/analysis ; Male ; Prospective Studies ; Sensitivity and Specificity ; Treatment Outcome
    Chemical Substances Biomarkers ; Leukocyte L1 Antigen Complex
    Language English
    Publishing date 2018-08-20
    Publishing country Germany
    Document type Journal Article ; Observational Study
    ZDB-ID 194196-3
    ISSN 1432-1076 ; 0340-6199 ; 0943-9676
    ISSN (online) 1432-1076
    ISSN 0340-6199 ; 0943-9676
    DOI 10.1007/s00431-018-3228-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Low predictive value of histopathological scoring system for complications development in children with Crohn's disease.

    Fabian, Ondrej / Hradsky, Ondrej / Potuznikova, Kristyna / Kalfusova, Alena / Krskova, Lenka / Hornofova, Ludmila / Zamecnik, Josef / Bronsky, Jiri

    Pathology, research and practice

    2017  Volume 213, Issue 4, Page(s) 353–358

    Abstract: Objectives: In pediatric Crohn's disease (PCD), the benefit of microscopy in disease activity assessment and prediction of clinical outcome is, due to the focality and transmurality of the inflammation, disputable. We investigated whether ... ...

    Abstract Objectives: In pediatric Crohn's disease (PCD), the benefit of microscopy in disease activity assessment and prediction of clinical outcome is, due to the focality and transmurality of the inflammation, disputable. We investigated whether histopathological scoring system predicts complications in pediatric CD and correlates with endoscopical and clinical scores.
    Methods: We performed a retrospective study on 63 patients. Endoscopy in the time of diagnosis was evaluated using the Simple Endoscopic Score (SES) and histopathology with the Global Histology Activity Score, both in its original version (GHAS) and its modification (modGHAS). Pediatric Crohn's Disease Activity Index (PCDAI) was also calculated. The patients were grouped according to the presence or absence of defined complications (intraabdominal abscess or fistula, perianal fistulating disease or stricture impenetrable for endoscope or with prestenotic dilatation) during one year of follow-up, or the necessity to initiate anti-TNF treatment for persisting or relapsing active disease in the same time period. Associations were tested with Cox regression analysis.
    Results: SES was higher in patients with complications. However, in case of GHAS, modGHAS and PCDAI we did not find any significant association with complicated course of disease. SES above 16 points was revealed as an independent risk factor for complications development in PCD, in contrary to GHAS, modGHAS and PCDAI. We demonstrated only a weak correlation between GHAS, modGHAS and SES and no correlation between the histopathological scoring systems and PCDAI.
    Conclusions: In conclusion, the histopathological scoring system cannot be recommended as a reliable predictor of development of complications in children with CD.
    MeSH term(s) Adolescent ; Child ; Crohn Disease/complications ; Crohn Disease/pathology ; Endoscopy, Gastrointestinal ; Female ; Humans ; Male ; Predictive Value of Tests ; Retrospective Studies ; Severity of Illness Index
    Language English
    Publishing date 2017-04
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 391889-0
    ISSN 1618-0631 ; 0344-0338
    ISSN (online) 1618-0631
    ISSN 0344-0338
    DOI 10.1016/j.prp.2017.01.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Prediction of Thiopurine Metabolite Levels Based on Haematological and Biochemical Parameters.

    Hradsky, Ondrej / Potuznikova, Kristyna / Siroka, Jitka / Lerchova, Tereza / Urbanek, Lubor / Mihal, Vladimir / Spenerova, Michaela / Velganova-Veghova, Maria / Karaskova, Eva / Bronsky, Jiri

    Journal of pediatric gastroenterology and nutrition

    2019  Volume 69, Issue 4, Page(s) e105–e110

    Abstract: Objectives: Therapeutic drug monitoring of thiopurine erythrocyte levels is not available in all centers and it usually requires quite a long time to obtain the results. The aims of this study were to build a model predicting low levels of 6-thioguanine ...

    Abstract Objectives: Therapeutic drug monitoring of thiopurine erythrocyte levels is not available in all centers and it usually requires quite a long time to obtain the results. The aims of this study were to build a model predicting low levels of 6-thioguanine and 6-methylmercaptopurine in pediatric inflammatory bowel disease (IBD) patients and to build a model to predict nonadherence in patients treated with azathioprine (AZA).
    Methods: The study consisted of 332 observations in 88 pediatric IBD patients. Low AZA dosing was defined as 6-thioguanine levels <125 pmol/8 × 10 erythrocytes and 6-methylmercaptopurine levels <5700 pmol/8 × 10 erythrocytes. Nonadherence was defined as undetectable levels of 6-thioguanine and 6-methylmercaptopurine <240 pmol/8 × 10 erythrocytes. Data were divided into training and testing part. To construct the model predicting low 6-thioguanine levels, nonadherence, and the level of 6-thioguanine, the modification of random forest method with cross-validation and resampling was used.
    Results: The final models predicting low 6-thioguanine levels and nonadherence had area under the curve, 0.87 and 0.94; sensitivity, 0.81 and 0.82; specificity, 0.80 and 86; and distance, 0.31 and 0.21, respectively, when applied on the testing part of the dataset. When the final model for prediction of 6-thioguanine values was applied on testing dataset, a root-mean-square error of 110 was obtained.
    Conclusions: Using easily obtained laboratory parameters, we constructed a model with sufficient accuracy to predict patients with low 6-thioguanine levels and a model for prediction of AZA treatment nonadherence (web applications: https://hradskyo.shinyapps.io/6TG_prediction/ and https://hradskyo.shinyapps.io/Non_adherence/).
    MeSH term(s) Adolescent ; Area Under Curve ; Child ; Drug Monitoring ; Erythrocytes/metabolism ; Female ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/pharmacokinetics ; Immunosuppressive Agents/therapeutic use ; Inflammatory Bowel Diseases/blood ; Inflammatory Bowel Diseases/drug therapy ; Inflammatory Bowel Diseases/metabolism ; Male ; Medication Adherence ; Mercaptopurine/administration & dosage ; Mercaptopurine/analogs & derivatives ; Mercaptopurine/pharmacokinetics ; Mercaptopurine/therapeutic use ; Models, Biological ; Predictive Value of Tests ; Sensitivity and Specificity ; Thioguanine/metabolism
    Chemical Substances Immunosuppressive Agents ; azathiopurine ; Mercaptopurine (E7WED276I5) ; Thioguanine (FTK8U1GZNX)
    Language English
    Publishing date 2019-05-25
    Publishing country United States
    Document type Evaluation Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 603201-1
    ISSN 1536-4801 ; 0277-2116
    ISSN (online) 1536-4801
    ISSN 0277-2116
    DOI 10.1097/MPG.0000000000002436
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top